| Mary O Landry, | |
|
220 S Jefferson St, Abbeville, LA 70510-5906 | |
| (337) 643-7965 | |
| Not Available |
| Full Name | Mary O Landry |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 220 S Jefferson St, Abbeville, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306925599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | R1548 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary O Landry, 138 E Bayou Shr, Lafayette, LA 70508-7921 Ph: () - | Mary O Landry, 220 S Jefferson St, Abbeville, LA 70510-5906 Ph: (337) 643-7965 |
News Archive
It's inappropriate to consider blanket do-not-resuscitate orders for COVID-19 patients because adequate data is not yet available on U.S. survival rates for in-hospital resuscitation of COVID-19 patients and data from China may not relate to U.S. patients, according to a new article published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
A team of researchers from the Cancer Science Institute of Singapore at the National University of Singapore has found that controlling the levels of the TIP60 protein, which is a tumour suppressor, could potentially prevent the spread of breast cancer cells.
MBF Healthcare Partners, L.P. ("MBF"), a healthcare services focused private equity firm, announced its plans to invest up to $50 million of equity capital to support Simply Healthcare Plans of Florida, Inc. ("SHP"), an HMO based in Coral Gables, Florida. The equity investment will be used to fund expansion and acquisition efforts in Medicare and Medicaid. SHP is a licensed HMO in Florida that has been approved by the State to expand into the Medicare and Medicaid markets.
Boston BioCom LLC today announced the successful completion of a collaborative research agreement between its Jantibody Therapeutics LLC subsidiary and Pfenex Inc., resulting in the rapid production of a HSP-avidin fusion protein for the Jantibodies self-assembling vaccines platform.
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.
› Verified 4 days ago
Christine F. Duhon, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Jefferson St, Abbeville, LA 70510 Phone: 337-898-5816 | |
Mrs. Jessica F Bourgeois, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Jefferson St, Abbeville, LA 70510 Phone: 337-893-3887 | |
Mrs. Lynette L Sheffield, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Jefferson St, Abbeville, LA 70510 Phone: 337-893-2899 | |
Rachel Camille Kesel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1105 Prairie Ave, Abbeville, LA 70510 Phone: 337-893-3943 | |
Miss Lynnly Cupstid Hardee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Jefferson St, Abbeville, LA 70510 Phone: 337-898-5816 | |
Mrs. Leslie Wartelle Deroche, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Jefferson St, Abbeville, LA 70510 Phone: 337-893-4978 | |
Mrs. Kayla Nicole Coreil, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S. Jefferson St, Abbeville, LA 70510 Phone: 337-857-3744 |